PTEN and cancer: This pathway is also one of the most frequently dysregulated signaling pathway in human cancers; this dysregulation has largely been attributed to the inactivation of the functionof a tumor suppressor gene Phosphatase and tensin homolog (PTEN), which is a negative regulator of the PI3K pathway and is associated with its increased activity resulting in various human cancers as also reflected by our complement pathway analysis.